February 16, 2016 Nutra Pharma is announcing today the first of several growth steps that will expand the Company’s core business strengths as well as its reach into important commercial markets. February 16, 2016 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunod